Kidney Stones Mounjaro: Risk, Safety & UK Guide

Clinically Proven UK Registered Pharmacy

Kidney Stones Mounjaro UK - From £124.99

Mounjaro from £124.99 with £20 off first order using code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off for new customers

Treatment from £124.99

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check your BMI

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£109 £89.00

£22.25 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £109
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy (Oral Pill)
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy (Oral Pill)
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy (Oral Pill)
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy (Oral Pill)
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Understanding Kidney Stones and Mounjaro: UK Safety Guide

Published: 11 September 2026

Concerns about kidney stones Mounjaro connections have emerged among patients considering tirzepatide for weight loss in the UK. While Mounjaro (tirzepatide) is a highly effective GLP-1 receptor agonist approved by the MHRA for weight management, understanding its renal safety profile and any potential impact on kidney stone formation is essential for informed treatment decisions. Our UK-registered clinical team provides comprehensive guidance on kidney health monitoring throughout your Mounjaro journey.

Does Mounjaro Cause Kidney Stones: Clinical Evidence

The relationship between kidney stones Mounjaro treatment remains an area of active clinical monitoring, though current evidence does not establish tirzepatide as a direct cause of kidney stone formation [1]. In the landmark SURPASS clinical trial programme involving over 6,000 participants, kidney stones were not identified as a significant adverse event associated with Mounjaro use. However, certain mechanisms related to GLP-1 receptor agonists warrant careful consideration for renal health.

Rapid weight loss achieved through Mounjaro treatment may theoretically increase urinary uric acid and calcium excretion, factors that can contribute to kidney stone formation in susceptible individuals [2]. Additionally, gastrointestinal side effects such as nausea, vomiting, and diarrhoea—common during initial Mounjaro titration—may lead to dehydration if fluid intake is inadequate. Dehydration is a well-established risk factor for kidney stone development, making hydration particularly important for patients using tirzepatide.

Our superintendent pharmacist Tarun Kumar emphasises that kidney stones Mounjaro concerns should be addressed through proper patient screening and ongoing monitoring rather than avoiding this effective treatment. Patients with a personal or family history of kidney stones, chronic kidney disease, or conditions like hyperparathyroidism should disclose these factors during their clinical assessment to ensure appropriate safety monitoring throughout treatment.

Kidney Stones Mounjaro Risk Factors and Prevention Strategies

Preventing kidney stones while using Mounjaro requires understanding individual risk factors and implementing targeted preventive measures. Patients with elevated baseline risk—including those with previous kidney stone episodes, metabolic syndrome, gout, or inflammatory bowel disease—should work closely with their prescriber to establish a comprehensive monitoring plan [3].

Adequate hydration represents the single most effective preventive strategy for kidney stones Mounjaro patients can implement. Clinical guidance recommends consuming at least 2.5 to 3 litres of fluid daily, with water as the primary source. This increased fluid intake helps dilute urinary concentrations of stone-forming substances such as calcium oxalate, uric acid, and cystine. Patients experiencing significant gastrointestinal side effects from Mounjaro should be particularly vigilant about fluid replacement to prevent dehydration-related stone formation.

Dietary modifications can further reduce kidney stone risk during Mounjaro treatment. Limiting sodium intake to less than 2,300mg daily helps reduce urinary calcium excretion, while maintaining adequate dietary calcium (1,000-1,200mg daily from food sources) paradoxically reduces oxalate absorption and stone risk [4]. Patients should avoid excessive animal protein consumption and consider reducing oxalate-rich foods such as spinach, rhubarb, and almonds if they have a history of calcium oxalate stones. Our UK clinical team provides personalised dietary guidance as part of your Mounjaro treatment plan, available from £124.99 following online assessment.

Monitoring Kidney Function During Mounjaro Treatment

Regular monitoring of kidney function is essential for patients concerned about kidney stones Mounjaro connections or those with pre-existing renal conditions. Baseline kidney function tests, including serum creatinine and estimated glomerular filtration rate (eGFR), should be obtained before starting tirzepatide therapy. Follow-up testing is typically recommended at 3-6 month intervals, or more frequently for patients with reduced kidney function or other risk factors.

Urinalysis can detect early signs of kidney stone formation, such as microscopic haematuria (blood in urine), crystalluria (crystals in urine), or pH abnormalities that favour stone development. Patients experiencing symptoms such as flank pain, painful urination, or visible blood in urine should seek immediate medical assessment, as these may indicate active kidney stone passage. All prescription Mounjaro treatment through Cured Pharmacy includes access to our UK-registered clinical team for ongoing safety monitoring and symptom assessment.

Kidney Stones Mounjaro Symptoms: When to Seek Medical Attention

Recognising potential kidney stones Mounjaro symptoms enables prompt intervention and prevents complications. Classic kidney stone symptoms include sudden, severe pain in the back, side, lower abdomen, or groin (renal colic), which may fluctuate in intensity as the stone moves through the urinary tract. This pain is often described as one of the most intense sensations patients experience and typically cannot be relieved by positional changes.

Additional symptoms that may indicate kidney stone formation during Mounjaro treatment include persistent nausea and vomiting (beyond typical GLP-1 side effects), pink, red, or brown discolouration of urine, cloudy or foul-smelling urine, frequent urination, urgent need to urinate, or burning sensation during urination [5]. Fever and chills accompanying these symptoms may signal urinary tract infection secondary to stone obstruction, requiring urgent medical evaluation.

Patients using Mounjaro should contact their healthcare provider if they experience any of these symptoms, even if mild. While kidney stones Mounjaro associations remain uncommon based on current evidence, early detection and management prevent potential complications such as urinary obstruction, infection, or kidney damage. Our clinical team at Cured Pharmacy provides ongoing support throughout your treatment journey, with transparent pricing from £124.99 and free online consultation completed in under 3 minutes.

Treatment Type Renal Monitoring Starting Price
Mounjaro (Tirzepatide) GLP-1/GIP Injection Baseline + periodic £145.00
Wegovy (Semaglutide) GLP-1 Injection Baseline + periodic £89.00
Wegovy Oral Tablets GLP-1 Pill Baseline + periodic £83.00
Saxenda (Liraglutide) GLP-1 Injection Baseline + periodic £68.00
Orlistat Lipase Inhibitor Not routinely required £32.00
Xenical (Orlistat) Lipase Inhibitor Not routinely required £49.99
Alli (Orlistat 60mg) Lipase Inhibitor Not routinely required £49.99

Comparing Kidney Stones Risk Across Weight Loss Medications

Understanding kidney stones Mounjaro risk in context requires comparing renal safety profiles across different weight loss medications available in the UK. GLP-1 receptor agonists as a class—including Mounjaro (tirzepatide), Wegovy (semaglutide), and Saxenda (liraglutide)—share similar mechanisms that may indirectly influence kidney stone risk through rapid weight loss and gastrointestinal effects, though none are directly nephrotoxic [6].

Orlistat-based treatments (Xenical, Alli, Orlos) present a different renal consideration. By blocking fat absorption in the intestine, orlistat increases intestinal fat content, which binds dietary calcium and increases oxalate absorption. This mechanism has been associated with increased risk of calcium oxalate kidney stones in some studies, particularly in patients with inflammatory bowel disease or those who have undergone bariatric surgery [7]. Patients with a history of kidney stones may therefore require more careful consideration when choosing between GLP-1 therapies and orlistat-based treatments.

The comparison table below outlines kidney stones Mounjaro and alternative weight loss treatments available through Cured Pharmacy. All prescription medications require clinical assessment by our UK-registered prescribers to evaluate individual risk factors, including renal health history, and determine the most appropriate treatment option for your circumstances.

Renal Safety Monitoring Across Treatment Options

Different weight loss medications require varying levels of kidney function monitoring. GLP-1 receptor agonists including Mounjaro generally require baseline and periodic kidney function assessment, with more frequent monitoring for patients with pre-existing renal impairment or dehydration risk. Tirzepatide has been studied in patients with moderate renal impairment (eGFR 30-59 mL/min/1.73m²) and showed acceptable safety profiles, though dose adjustments are not routinely required based on kidney function alone.

Orlistat does not require routine kidney function monitoring in most patients, as it acts locally in the gastrointestinal tract with minimal systemic absorption. However, the increased oxalate absorption associated with orlistat necessitates specific counselling about kidney stone prevention for susceptible patients. Our clinical team evaluates your complete medical history, including any history of kidney stones, Mounjaro candidacy, and alternative treatment options during your confidential online assessment.

Managing Kidney Stones Mounjaro Treatment: Clinical Protocols

For patients who develop kidney stones while using Mounjaro, treatment decisions depend on stone size, location, symptoms, and individual patient factors. Small stones (less than 5mm) often pass spontaneously with conservative management including increased fluid intake, pain control with NSAIDs or paracetamol (subject to prescriber approval), and alpha-blocker medications to facilitate stone passage [8]. During this period, Mounjaro treatment may be continued under close medical supervision if the stone is passing without complications.

Larger stones or those causing significant obstruction may require urological intervention such as extracorporeal shock wave lithotripsy (ESWL), ureteroscopy with stone removal, or percutaneous nephrolithotomy for very large stones. In these cases, your prescriber will assess whether to temporarily discontinue Mounjaro during the acute management phase, particularly if procedures requiring general anaesthesia are planned or if dehydration risk is elevated.

Following kidney stone resolution, resuming kidney stones Mounjaro treatment requires careful consideration of the underlying stone composition and contributing factors. Stone analysis (when stones are retrieved) guides preventive strategies—calcium oxalate stones may warrant dietary oxalate restriction, uric acid stones benefit from urinary alkalinisation, and cystine stones require specific management protocols. Our UK clinical team coordinates with your NHS GP or specialist to ensure comprehensive care continuity while providing convenient access to Mounjaro from £124.99 with £20 off your first order using code Weightlossnew.

Kidney Stones Mounjaro: Long-Term Safety and Patient Outcomes

Long-term data on kidney stones Mounjaro associations continue to accumulate as tirzepatide gains wider clinical use in the UK and internationally. Post-marketing surveillance and real-world evidence studies have not identified kidney stone formation as a common adverse event, supporting the safety profile established in clinical trials. However, vigilance remains important as individual patient factors and longer treatment durations may reveal patterns not apparent in controlled trial settings.

The substantial weight loss achieved with Mounjaro—averaging 15-20% of body weight in clinical trials—provides significant renal health benefits that may outweigh theoretical kidney stone risks for many patients [1]. Obesity itself is an independent risk factor for chronic kidney disease progression, and weight reduction improves kidney function markers, reduces proteinuria, and decreases progression to end-stage renal disease in patients with obesity-related kidney disease. This broader renal benefit context is essential when evaluating kidney stones Mounjaro concerns.

Patient education and shared decision-making form the cornerstone of safe Mounjaro prescribing in the UK. During your clinical assessment at Cured Pharmacy, our prescribers discuss your individual risk profile, including any history of kidney stones, family history of renal disease, current kidney function, and hydration habits. This personalised approach ensures that kidney stones Mounjaro concerns are appropriately addressed while enabling access to this highly effective weight loss treatment. All medications are UK-licensed and sourced from registered wholesalers, with 100% discreet packaging and lowest prices guaranteed in the UK.

Patient Support and Ongoing Clinical Care

Ongoing support throughout your Mounjaro journey includes access to our UK-registered clinical team for questions or concerns about side effects, including any symptoms suggestive of kidney stones. Our transparent pricing model shows costs upfront before consultation, with Mounjaro available from £124.99 following clinical assessment. Free online consultation takes under 3 minutes to complete, and approved prescriptions are dispensed by our GPhC-registered pharmacy (registration number 9012511) with next-day delivery options available.

We encourage patients to maintain regular follow-up with their NHS GP for routine health monitoring, including kidney function tests, while using Mounjaro. This collaborative care model ensures comprehensive safety oversight while providing convenient access to specialist weight loss medications. For any concerns about kidney stones Mounjaro treatment or to begin your clinical assessment, contact our team at (+44) 116 4646009 or complete the online consultation on our website.

Scientific References

  1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 11 September 2026]
  2. Lieske, J. C., de la Vega, L. S., Gettman, M. T., et al. (2006). Diabetes mellitus and the risk of urinary tract stones: a population-based case-control study. American Journal of Kidney Diseases, 48(6), 897-904. [accessed 11 September 2026]
  3. Scales, C. D., Smith, A. C., Hanley, J. M., & Saigal, C. S. (2012). Prevalence of kidney stones in the United States. European Urology, 62(1), 160-165. [accessed 11 September 2026]
  4. Curhan, G. C., Willett, W. C., Speizer, F. E., & Stampfer, M. J. (1997). Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Annals of Internal Medicine, 126(7), 497-504. [accessed 11 September 2026]
  5. Türk, C., Petřík, A., Sarica, K., et al. (2016). EAU guidelines on diagnosis and conservative management of urolithiasis. European Urology, 69(3), 468-474. [accessed 11 September 2026]
  6. Gerstein, H. C., Colhoun, H. M., Dagenais, G. R., et al. (2021). Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial. Lancet, 394(10193), 131-138. [accessed 11 September 2026]
  7. Sinha, M. K., Collazo-Clavell, M. L., Rule, A., et al. (2007). Hyperoxaluric nephrolithiasis is a complication of Roux-en-Y gastric bypass surgery. Kidney International, 72(1), 100-107. [accessed 11 September 2026]
  8. Hollingsworth, J. M., Rogers, M. A., Kaufman, S. R., et al. (2006). Medical therapy to facilitate urinary stone passage: a meta-analysis. Lancet, 368(9542), 1171-1179. [accessed 11 September 2026]
  9. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 11 September 2026.
  10. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 11 September 2026.
  11. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 11 September 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

Can Mounjaro cause kidney stones directly?
Current clinical evidence does not establish Mounjaro as a direct cause of kidney stones. However, rapid weight loss and dehydration from gastrointestinal side effects may indirectly increase risk in susceptible individuals, making adequate hydration essential during treatment.
What are the symptoms of kidney stones while taking Mounjaro?
Kidney stone symptoms include severe flank or abdominal pain, blood in urine, painful urination, nausea beyond typical Mounjaro side effects, and frequent urgent urination. Contact your healthcare provider immediately if these symptoms occur during treatment.
How much water should I drink on Mounjaro to prevent kidney stones?
Clinical guidance recommends consuming 2.5 to 3 litres of water daily while using Mounjaro to maintain adequate hydration and reduce kidney stone risk. Increase intake further if experiencing gastrointestinal side effects like vomiting or diarrhoea.
Should I avoid Mounjaro if I've had kidney stones before?
A history of kidney stones does not automatically exclude Mounjaro use, but requires careful assessment by a UK prescriber. Enhanced monitoring, preventive strategies including increased hydration, and dietary modifications can enable safe treatment in many cases subject to clinical approval.
Does Mounjaro affect kidney function long-term?
Mounjaro does not directly damage kidney function and may improve renal health through substantial weight loss. Clinical trials showed acceptable safety in patients with moderate kidney impairment, though regular monitoring is recommended for all patients.
Is kidney stone risk higher with Mounjaro or orlistat?
Orlistat has been more directly associated with increased calcium oxalate kidney stone risk due to increased oxalate absorption, particularly in susceptible patients. Mounjaro's kidney stone risk appears primarily related to dehydration rather than direct metabolic effects.
What tests monitor kidney health during Mounjaro treatment?
Baseline and periodic kidney function tests including serum creatinine and eGFR are recommended for Mounjaro patients. Urinalysis may be performed if symptoms suggest kidney stones or in patients with elevated baseline risk factors.
Can I continue Mounjaro if I develop a kidney stone?
Treatment decisions depend on stone size, symptoms, and complications. Small stones passing spontaneously may allow continued Mounjaro use under medical supervision, while larger stones requiring intervention may warrant temporary discontinuation subject to prescriber assessment.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Last reviewed: 11 September 2026

Last updated on 11 September 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 11 September 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (11 September 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.